Shilpa Medicare Limited announced about issue of redeemable non-convertible debentures for its 2 wholly owned subsidiaries as detailed below, in connection with the issue of: (i) 12,500 (Twelve Thousand Five Hundred) senior, secured, rated, unlisted and redeemable non-convertible debentures of the face value of INR 100,000 each on a private placement basis, and aggregate nominal value of up to INR 1,250,000,000 (the Series-I Debentures); and (ii) 22,500 senior, secured, rated, unlisted and redeemable non-convertible debentures of the face value of INR 100,000 each on a private placement basis, and aggregate nominal value of up to INR 2,250,000,000 (the "Series-II Debentures") by Shilpa Pharma Lifesciences Limited ("SPLL"); 10,000 senior, secured, rated, unlisted and redeemable non-convertible debentures of the face value of INR 100,000 each on a private placement basis, and aggregate nominal value of up to INR 1,000,000,000 (the "SBPL Debentures") by Shilpa Biologicals Private Limited ("SBPL").